DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Stock

Certificat

DE000ME9LNA0

Market Closed - Börse Stuttgart 14:17:54 2024-06-12 EDT
0.159 EUR -11.67% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-58.16%
1 month-64.67%
Date Price Change
24-06-12 0.159 -11.67%
24-06-11 0.18 -12.20%
24-06-10 0.205 -31.67%
24-06-07 0.3 -3.23%
24-06-06 0.31 -3.13%

Delayed Quote Börse Stuttgart

Last update June 12, 2024 at 02:17 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME9LNA
ISINDE000ME9LNA0
Date issued 2024-03-05
Strike 80 $
Maturity 2024-09-20 (100 Days)
Parity 10 : 1
Emission price 0.35
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.61
Lowest since issue 0.159
Spread 0.008
Spread %5.03%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
61.69 USD
Average target price
88.55 USD
Spread / Average Target
+43.55%
Consensus